"Founded in 1882, Jersey City Medical Center (JCMC) is located on a 15‐acre campus overlooking the New York Harbor and Liberty State Park. The hospital serves as a regional referral and teaching hospital providing the highest level of care for women and infants, trauma and cardiac patients. Our renowned medical professionals use the latest technologies to provide unparalleled care with compassion. Jersey City Medical Center is the provider of Advanced Life Support for Hudson County, is a Regional Trauma Center, a Level III Regional Neonatal Intensive Care Center and a Regional Heart Hospital with cardiac surgery."

During the past decade, Jersey City Medical Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jersey City Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 3 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "RWJ Barnabas Health at Jersey City Medical Center" with 3 trials sponsored, "Rutgers, The State University of New Jersey" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jersey City Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Seagen Inc." with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Jersey City Medical Center" are "Anatomic Stage II Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIA Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIB Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIIA Breast Cancer AJCC v8" (2 trials) and "Endometrial Cancer" (2 trials). Many other conditions were trialed in "Jersey City Medical Center" in a lesser frequency.

Most popular intervention types in "Jersey City Medical Center" are "Drug" (10 trials), "Other" (7 trials), "Biological" (4 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (3 trials), "Questionnaire Administration" (3 trials), "Cisplatin" (2 trials), "Paclitaxel" (2 trials) and "Trastuzumab Emtansine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Jersey City Medical Center" are 15 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Jersey City Medical Center". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Jersey City Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jersey City Medical Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Jersey City Medical Center has several departments that took part in Clinical trials: "Rutgers Cancer Institute of New Jersey,414 Grand Street" - 2 trials